Versican in epithelial ovarian cancer: R
β
Kirsi Voutilainen; Maarit Anttila; Sari SillanpÀÀ; Raija Tammi; Markku Tammi; Se
π
Article
π
2003
π
John Wiley and Sons
π
French
β 216 KB
## Abstract Versican, a proteoglycan previously reported to increase in other malignant tumours, was studied immunohistochemically in 299 primary epithelial ovarian cancers, their 43 metastases and 6 normal ovaries to evaluate its prognostic value and relation to hyaluronan, another extracellular m